Ballentine Partners LLC Boosts Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Ballentine Partners LLC raised its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 64.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,205 shares of the biotechnology company’s stock after purchasing an additional 472 shares during the period. Ballentine Partners LLC’s holdings in Axon Enterprise were worth $716,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of AXON. Quent Capital LLC grew its holdings in Axon Enterprise by 1,875.0% during the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after buying an additional 75 shares during the last quarter. Prestige Wealth Management Group LLC lifted its position in shares of Axon Enterprise by 115.8% in the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after acquiring an additional 44 shares in the last quarter. Brooklyn Investment Group acquired a new stake in shares of Axon Enterprise during the third quarter valued at $41,000. Planning Capital Management Corp increased its position in Axon Enterprise by 83.3% during the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after purchasing an additional 55 shares in the last quarter. Finally, Friedenthal Financial acquired a new position in Axon Enterprise in the 3rd quarter valued at about $51,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Axon Enterprise Stock Up 0.3 %

AXON opened at $607.60 on Thursday. Axon Enterprise, Inc. has a 1 year low of $247.04 and a 1 year high of $698.67. The firm has a 50 day moving average price of $617.26 and a 200 day moving average price of $466.40. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The company has a market cap of $46.33 billion, a PE ratio of 157.00, a price-to-earnings-growth ratio of 5.95 and a beta of 1.04.

Insider Transactions at Axon Enterprise

In related news, insider Jeffrey C. Kunins sold 21,834 shares of the stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total value of $12,966,775.92. Following the completion of the sale, the insider now directly owns 154,394 shares in the company, valued at approximately $91,691,508.72. This represents a 12.39 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the transaction, the director now owns 6,929 shares in the company, valued at approximately $4,185,601.03. This represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 50,545 shares of company stock valued at $30,721,337 over the last 90 days. Corporate insiders own 5.70% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently commented on AXON shares. TD Cowen started coverage on shares of Axon Enterprise in a report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price target for the company. Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their target price for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. JMP Securities increased their price target on Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research note on Thursday, October 31st. The Goldman Sachs Group raised their price objective on Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. Finally, Needham & Company LLC upped their target price on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research note on Friday, November 8th. One equities research analyst has rated the stock with a hold rating and fourteen have given a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $504.92.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.